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The aim of the present study was to compare carotenoid 
extracts of Rose hips (Rosa canina L.) with regard to their 
phytochemical profiles and their in vitro anti-Helicobacter 
pylori (H. pylori), cytotoxic, multidrug resistance (MDR) 
reversal and radical scavenging activity. Carotenoid 
composition was investigated in the different fractiona-
tion of rose hips, using extraction methods. Six main ca-
rotenoids — epimers of neochrome, lutein, zeaxanthin, 
rubixanthin, lycopene, β,β-carotene — were identified 
from Rose hips by their chromatographic behavior and 
UV-visible spectra, which is in accordance with other 
studies on carotenoids in this plant material. The active 
principles in the carotenoid extract might differ, depend-
ing upon the extraction procedures.
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INTRODUCTION
Carotenoids play an important role in preventing oxi-
dative damage which are caused by free radicals in age-
related diseases such as cancer and ageing (Britton et al., 
2005; Motohashi et al., 2003; Krinsky & Johnson, 2005). 
Most current research is focused on a proposed role of 
carotenoids as lipid antioxidants which can protect the 
cells or hosts from the oxidation and other destructive 
processes mediated by singlet oxygen and free radicals, 
though more specific effects on the immune system are 
now under investigation (Britton et al., 2005; Krinsky & 
Johnson, 2005). In this study, we present qualitative and 
quantitative data on the carotenoid content of Rose hips. 
We investigated anti-Helicobacter pylori (H. pylori), cytotox-
ic, multidrug resistance (MDR) reversal and radical scav-
enging activity by the carotenoid extracts of Rose hips.
MATERIALS AND METHODS
Chemicals and reagents. They were obtained from 
the indicated companies: RPMI 1640 medium and Dul-
becco’s modified Eagle medium (DMEM) (Gibco BRL, 
Grand Island, NY, USA); fetal bovine serum (FBS) (JRH 
Bioscience, Lenexa, KS, USA); 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT), metronida-
zole, ascorbic acid, Rose Bengal and 2,2,6,6-tetramethyl-
4-hydroxy-piperideine (4-OH TEMP) (Wako Pure Chem. 
Ind., Ltd., Osaka, Japan); 1,1-diphenyl-2-picrylhydrazyl 
(DPPH) (Sigma Chem. Co., St. Louis, MO, USA); dex-
tran sulphate (DS, 8 kD), (Kowa Chem. Co., Tokyo, 
Japan); β,β-carotene and gallic acid (Tokyo Kasei Co., 
Tokyo, Japan); clarithromycin (Taisho Pharmaceutical 
Co., Tokyo, Japan). α-Tocopherol was a gift from Eisai 
Ltd. (Tokyo, Japan). A strain of H. pylori (ATCC 43504) 
was purchased from American Type Culture Collection 
(Rockville, MD, USA). 
Isolation of phytoxanthins from Rose hips (Rosa 
canina L.). Rose hips (1.2 kg fresh weight) have been 
collected in the surroundings of Pécs (Hungary). Isola-
tion of PM2 and PM9-PM12 in crystalline state was 
carried out in our laboratory according to reference of 
Molnár et al. (2005a). PM2: Phytoxanthins of Rose hips, 
680 mg crystalline sample; PM9: Hypophasic carotenoids 
of the ethereal extract of Rose hips, 176 mg crystalline 
sample; PM10: Epiphasic carotenoids of the ethereal ex-
tract of Rose hips, 350 mg crystalline sample; PM11: Hy-
pophasic carotenoids of the MeOH extract of Rose hips, 
96 mg crystalline sample; PM12: Epiphasic carotenoids 
of the MeOH extract of Rose hips, 180 mg crystalline 
sample.
HPLC analysis of samples PM2, PM9-12. HPLC 
was performed on a Dionex 580P NDG pump (Dionex 
Softron Germering, Germany) connected to a Dionex 
PDA-100 detector running Dionex Chromeleon soft-
ware. Column: 250 mm × 4.6 mm i.d., 6 mm, endcapped 
Chromsyl C18. Gradient elution was performed with mix-
ture of mobile phases as follows: A, 12% H2O in MeOH; 
B, MeOH: ad C, 30% CH2Cl2 in MeOH. Gradient pro-
gram: 0–2 min, 100% A; 2–10 min, to 80% A 20% B; 
10–18 min, to 50% A 50% B; 18–25 min, to 100% B; 
25–27 min, 100% B, 27–34 min, to 100% C; 34–41 min, 
10% C (in linear steps); flow rate: 1.2 ml/min. Peak iden-
tification was at 450 nm (Deli et al., 2000). Carotenoids 
were identified on the basis of their UV-Vis spectroscopic 
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properties in different solvents, chemical reactions [(E/Z)-
isomerization (thermal isomerization and iodine-catalized 
photoisomerization), 5,6-epoxide → 5,8-epoxide (furanoid 
oxide) rearrangement, NaBH4-reduction], by co-chroma-
tography with authentic reference samples (purity: >95%; 
HPLC) and by HPLC retention times (Deli et al., 2000). 
Measurement of anti-H. pylori activity. The micro-
dilution broth method was used to determine the minimum 
inhibitory concentration (MIC). Brain Heart Infusion (BHI) 
broth containing 10% fetal bovibe serum (FBS) and 0.1% 
glucose was used as the medium and was cultured in a jar 
conditioned with AnaeroPack (Campylo, Mitsubishi Gas 
Chemical Co., Inc.). H. pylori was inoculated in the medi-
um and cultured at 37°C for 2 days. The collected bacte-
rial colonies were diluted to about 107 colony forming unit 
(CFU)/ml with the medium. The fractions were dissolved 
in DMSO, and then diluted with the medium. To the solu-
tion of the fractions, a suspension of bacteria was added to 
make 106 CFU/150 mL/well. The mixture was incubated 
at 37°C for 5 days. The MIC values of the fractions were 
determined by observation (Kawase et al., 2003). 
Cell culture. Human oral squamous cell carcinoma 
(HSC-2) cells (provided from Prof. Nagumo, Showa 
University) and human submandibular gland tumor (HSG) 
cells (provided from Dr. Atsumi, Meikai University) were 
maintained as monolayer cultures at 37°C in Dulbecco’s 
modified Eagle medium (DMEM) supplemented with 
10% heat-activated FBS in a humidified 5% CO2 atmo-
sphere, and subcultured by trypsinization. Human gingival 
fibroblasts (HGF) were isolated from the periodontal tis-
sue of healthy gingival biopsy of a 10-year-old female, as 
described previously (Sakagami et al., 2000), according to 
the guideline of Meikai University Ethic Committee, after 
obtainig the informed consent from the patients. Cells be-
tween the fifth and seventh passages were used.
Measurement of cytotoxic activity. Near confluent 
HSC-2 and HSG cells were incubated for 24 h with the 
indicated concentrations of test samples in culture medi-
um in 96-microwell plates (Becton Dickinson and Com-
pany, Franklin Lakes, NJ, USA), and the viable cell num-
ber was determined by MTT method (Sakagami et al., 
2000). The cells were washed with PBS, and incubated 
for 4 h with fresh culture medium containing 0.2 mg/
mL MTT. After removing the medium, cells were lysed 
with 100 mL DMSO and the absorbance at 540 nm of 
the cell lysate was measured with Labsystems MutiskanR 
with Star/DOT Matrix printer JL-10. The A540 values of 
control HSC-2, HSG and HGF cells were 1.519, 0.884, 
and 0.283, respectively. We found that the linearity of 
the absorbance value was maintained between 0–2.0. The 
absorbance value of 1.0 was correlated to approximately 
4×104 cells/cm2. The 50% cytotoxic concentration 
(CC50) was determined from the dose-response curve. 
Measurement of the MDR reversal activity. The 
MDR1/A expressing cells were selected by culturing the 
infected cells with 60 ng/mL colchicine to maintain the ex-
pression of the MDR phenotype (Kessel, 1989). The L5178 
MDR cell and the L5178 Y parent cell were grown in Mc-
Coy’s 5A medium supplemented with 10% heat-inactivated 
horse serum, L-glutamine and antibiotics. The cells were 
adjusted to a concentration of 2×106/ml and resuspended 
in serum-free McCoy’s 5A medium, and 0.5 ml aliquot of 
the cell suspension were distributed into each Eppendorf 
centrifuge tube. Then 10 µl of 2 mg/ml test compounds 
(dissolved in DMSO) were added and incubated for 10 min 
at room temperature. Then 10 µl rhodamine 123 as indi-
cator of drug accumulation was added to the extracts (5.2 
µM final concentration) and the cells were incubated for a 
further 20 min at 37°C, washed twice and resuspended in 
0.5 ml PBS (pH 7.4) for analysis. The fluorescence intensity 
of cell population was measured by flow cytometry (instru-
ment: Beckton Dickinson FACScan). (±)-Verapamil was 
used as the positive control in R123 accumulation experi-
ments (Weaver et al., 1993). The R123 accumulation was 
calculated from fluorescence of one height values. Then, 
the percentage of mean fluorescence intensity was calcu-
lated in treated MDR1 and parental cells, compared to un-
treated cells. The fluorescence activity ratio was calculated 
by following equation (Weaver et al., 1993): 
MDR1 reversal activity = (MDR1 treated/MDR1 control)/(pa-
rental treated/parental control)
Measurement of the radical scavenging activity
DPPH scavenging assay. For the determination of 
DPPH radical, 30 µL of 300 µM DPPH in EtOH were 
added to 60 µL of sample in 40% DMSO solution and 
analyzed 1 min after mixing. The microwave power, gain 
and time constant were changed to 5, 400 and 0.1 s, re-
spectively (Molnár et al., 2005b). 
1O2 scavenging assay. The sample was added to the 
reaction mixture of 20 mM 4-OH TEMP and 20 µM 
Rose Bengal in 20% DMSO solution and the mixture in 
flat cell was irradiated for 5 min at 550 nm and ana-
lyzed by using ESR spectrometer. The microwave pow-
er, modulation width, the gain and time constant were 
changed to 5, 0.2, 200 and 0.1 s. Singlet oxygen was 
measured by oxidation of 4-OH TEMP to 2,2,6,6-tetra-
methyl-4-hydroxy-1-piperidinyloxy (4-OH TEMPO) radi-
cal (Molnár et al., 2005b). 
RESULTS AND DISCUSSION
Carotenoid composition of PM2, and PM9-12 fractions
On the basis of UV-VIS spectrum of the peaks, as 
well as the retention time and co-cromatography with au-
thentic reference samples, the following carotenoids were 
identified in PM2 fraction (Molnár et al., 2001): antherax-
anthin: 5.9%; epimers of mutatoxanthin: 5.1%; lutein + 
zeaxanthin: 59.7%; (Z)-isomers of lutein and zeaxanthin: 
1.5%; rubixanthin + β-cryptoxanthin: 11.7%; lycopene + 
(Z)-lycopene: 7.4%; β,β-carotene: 1.5%. In the fraction 
of PM9 the following carotenoids were identified: (all-
E)-neoxanthin (1.3%); (9’Z)-neoxanthin (2.1%); epimers 
of neochrome (8.8%); epimers of auroxanthin (6.3%); lu-
tein + zeaxanthin (74.7%); (Z)-isomers of lutein and zea-
xanthin (2.1%); rubixanthin + β-cryptoxanthin (0.9%). 
The main carotenoids of PM10 fraction were lycopene 
(62.3%) and β,β-carotene (23.9%). The fraction of 
PM11 contained epimers of neochrome (6.1%); epimers 
Table 1. Anti-H. pylori activity of Rose hips carotenoids
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of auroxanthin (13.0%); antheraxanthin: 2.3%); lutein + 
zeaxanthin (53.7%); (Z)-isomers of lutein and zeaxan-
thin (7.3%); and rubixanthin + β-cryptoxanthin (2.8%). 
In the PM12 fraction lycopene (27.5%) and β,β-carotene 
(40.4%) were identified as the main components.
Anti-H. pylori activity
Helicobacter pylori is an important human pathogen that 
infects up to 50% of the human population. As the lead-
ing cause of peptic ulcers, gastritis and gastric cancer 
worldwide, the organism has been the subject of inten-
sive research to unravel the mysteries of its genetics and 
cellular biology. Antibacterial agents from a diet rich in 
fruit and vegetable may be superior as H. pylori control 
agents, when compared to many non-natural products 
(Kawase & Motohashi, 2004). Carotenoids, as free radi-
cals, play an important role in the pathogenesis of gas-
troduodenal mucosal inflammation, peptic ulcer disease, 
various micronutrients are considered to protect the gas-
tric mucosa by scavenging the free radicals. Among the 
tested PM2 and PM9-12 extracts only the PM10 and 11 
displayed some anti-H. pylori effects (MIC50= 8.2 µg/ml 
and 11 µg/ml) comparable to metronidazole (MIC50= 
7.0 µg/ml) (Table 1). The other compounds PM2, 9 and 
12 had moderate activity.
Cytotoxic activity
Carotenoids showed potent in vitro anti-tumor pro-
moting activity (Garewal, 1993). A higher intake of ca-
rotenoids-rich foods is associated with a reduced risk of 
Table 2. Cyctotoxic activity of Rose hips carotenoids against tumor and normal cells
Compound
50% cytotoxic concentration (CC50, µg/ml)
SIa= CC50 (normal)/ 
CC50 (tumor)
Human tumor cell Normal cell
  HSC-2 HSC-3 HSC-4 HepG2 T98G HL-60 HGF HPC HPLF
PM2 73 81 50 84 >100 15 89 69 96 <1.3
PM9 >200 98 77 188 >200 15 195 154 191 >1.4
PM10 44 79 36 71 160 14 144 85 152 1.9
PM11 12 38 23 14 68 3 78 25 98 2.5
PM12 154 161 104 145 >200 39 >200 85 >200 ><1.2
β,β-carotene 193 >200 – – - >200 >200 >200 >200 ><1.0
Gallic acid 19 29 – – - 24 81 75 49 2.48
A540 1.3 0.6 0.81 0.34 0.49   0.56 0.5 0.51  
Near confluent cells were incubated for 24 hours without or with various concentrations of each compound, and the relative viable cell number 
(absorbance at 540 nm of the MTT-stained cell lysate) was determined by the MTT method. The viable cell number of HL-60 cells was determined 
by trypan blue exclusion. The CC50 was determined from the dose-response curve. Each value represents the mean from duplicate determinations. 
adetermined by the equation: SI= [CC50(HGF) + CC50(HPC) + CC50(HPLF) / CC50(HSC-2) + CC50(HSC-3) + CC50(HSC-4 )+ CC50(HepG2) + CC50(T98G) + 
CC50(HL-60)] × 6/3. 
Table 3. Effect of Rose hips carotenoids on the multidrug resistance of L-5178 cells
Extract Concentration (µg/ml) FSCa SSCa FL-1a Fluorescence activity ratio
Par (control)b – 546.05 224.80 936.73
MDR + R123 (mean)c – 604.47 303.43 11.81 –
(dl)-Verapamil 10 581.09 296.13 86.27 7.30
DMSO 20 573.37 306.12 14.65 1.24
PM9 4 602.90 310.22 27.78 2.35
40 585.17 303.20 167.97 14.22
PM10 4 610.71 309.18 25.62 2.17
40 576.39 303.77 134.76 11.41
PM12 4 634.75 332.75 16.18 1.86
40 591.85 328.64 122.92 14.15
β,β-carotene 4 483.20 200.85 396.50 46.32
  40 493.89 197.99 1612.27 188.34
aFSC: Forward scatter count; SSC: Side scatter count; FL-1: Fluorescence intensity; bPar: a parenteral cell without MDR gene; cMDR: a parenteral cell 
transfected with MDR gene.
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the development of cancer formation. Capsanthin and re-
lated carotenoids isolated from the fruits of red paprika 
exhibited potent antitumor-promoting activity (Maoka et 
al., 2001). Cytotoxic activities of PM2, PM9-12 was com-
pared to β,β-carotene and gallic acid against six human 
tumor cell cultures and three normal cell cultures (Table 
2). The cytotoxic effect of PM compounds were in the 
same range but somewhat lower than that of gallic acid 
as control. The tumor-specific cytotoxicity as indicated by 
SI selective toxicity was only slightly observed in case of 
PM10 and PM11. The safety index (SI) values of PM10 
and PM11 were 1.9 and 2.5, respectively (Table 2).
MDR reversal on tumor cells
MDR is a major problem in cancer treatment. The 
overexpression of drug transport proteins is a major 
mechanism for the MDR. In tumor cells overexpressing 
P-glycoprotein (P-gp), this results in reduced intracellular 
drug concentrations which in turn decrease the efficacy of 
a broad spectrum of some antitumor drugs. Molnár and 
coworkers have recently examined MDR modulating ac-
tivity of several carotenoids and shown that capsanthin 
and capsorubin enhanced the drug accumulation most 
potently (Molnár et al., 2004). We measured the ability of 
PM9-10 and PM12 extracts to inhibit the P-gp mediated 
R-123 efflux in the MDR mouse T cell lymphoma L5178 
transfected by human MDR1 gene, which was cultured in 
colchicine-containing medium. The ability of PM9, 10 and 
12 was studied on the drug accumulation of MDR tumor 
cells. These extracts showed dose dependent reversal of 
ABC transporter. Interestingly the β,β-carotene was more 
effective the same concentrations on the MDR cells, how-
ever these concentrations were toxic for the tested cells as 
the SSC and FSC values shows (Table 3).
Radical scavenging activity
Carotenoids are involved in the scavenging of two 
of reactive oxigen species (ROS), singlet molecular ox-
ygen and peroxy radicals generated in the process of 
lipid peroxidation (Sies et al., 1993). At 400 µg/ml con-
centration PM9-10 and PM12 extracts showed lower 
singlet oxygen scavenging activity in comparison with 
the control β,β-carotene. In DPPH assay, the electron-
donating capacity was strongest in the following order: 
PM10>PM9>PM12>β,β-carotene (Table 4).
CONCLUSION
Carotenoids are important dietary nutrients having an-
tioxidant potential and are consequently being considered 
as important preventive strategic molecules. Antioxidants 
may protect against oxidative damages both by directly 
neutralizing reactive oxidants and by modulating gene 
expression contributing to oxidative stress (Silvaas et al., 
2004). A mixture of carotenoids with different chemical 
structures and different antioxidants might be a promising 
agent for the medicinal use than individual carotenoids.
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